The fund highlights the transformative impact of artificial intelligence across industries, suggesting that AI adoption is still early and could surpass the internet in economic influence. It also emphasizes opportunities in the biotechnology sector, particularly gene editing technologies such as CRISPR-Cas9 and base editing, which could redefine healthcare through functional cures. Contrarius views both AI and biotech as undervalued long-term growth themes with substantial innovation-driven upside.
This report provides a detailed summary of investor holdings for a
specified stock ticker, highlighting key metrics such as fund
name, total assets under management (AUM), invested value,
portfolio weight, and shares owned. It also tracks changes in
share ownership during the last quarter, including the percentage
of shares bought or sold and the percentage of outstanding shares
owned. The data is generated using an API that processes investor
holdings and calculates these values for each fund. This report
helps investors and analysts monitor the stock positions of major
funds, identify investment trends, and assess the influence of
large investors on individual stocks.